STAT Plus: A longtime health care investor recalls the insulin bong, praises discipline in valuations, and looks to South America
SPENCER PLATT/GETTY IMAGES
"Back in the ’90s, biotech investing was the Wild West. We didn't have the sophisticated scientist folks creating companies or analyzing companies."
No hay comentarios:
Publicar un comentario